Join to access to all OVN content. Join for Free
Why and How MSLs Can Adapt the Mindset of a Lifelong Learner
lifelong learning for MSLs personal accountability in learning engaging with KOLs platforms for MSL learning social media for professional growth

Why and How MSLs Can Adapt the Mindset of a Lifelong Learner


Share This Article


Summary

In this episode, Sarah Snyder shares her insights on lifelong learning for MSLs, emphasizing the importance of personal accountability and balancing different learning types. She discusses strategies for managing decision fatigue and setting achievable learning goals, providing valuable resources and book recommendations. Sarah encourages starting before feeling fully ready and highlights the significance of performance tracking. The conversation delves into engaging with KOLs and the potential of platforms like Clubhouse and TikTok for MSLs. Sarah concludes with advice on using social media strategically for professional growth, urging listeners to take action in their learning journey.

Sarah Snyder, Associate Director, Medical Affairs at Biosplice Therapeutics discusses why it is so important for MSLs to be lifelong learners.

Sarah shares…

👉 How to apply your learning style for success

👉 Resources and platforms that may be effective for MSL learning

👉 Why personal development can be as important as scientific learnings

👉 Her personal recommendations on recent books, podcasts, etc.

👉 How to tie personal development to performance

Click for Source
lifelong learning for MSLs, personal accountability in learning, engaging with KOLs, platforms for MSL learning, social media for professional growth

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Article
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
OVN Avatar Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN